Stockreport

KKR and Impilo Announce Strategic Partnership Together With Management in Rare Disease Platform Immedica Pharma

KKR & Co. Inc.  (KKR) 
Last kkr & co. inc. earnings: 1/31 06:50 am Check Earnings Report
US:NYSE Investor Relations: ir.kkr.com
PDF STOCKHOLM & LONDON--(BUSINESS WIRE)--Investment funds managed by KKR, a leading global investment firm, have agreed to acquire Immedica Pharma, a pharmaceutical comp [Read more]